Cargando…
p53 protein is absent from the serum of patients with lung cancer.
p53 protein, which accumulates intracellularly in over half of all human tumours, has also been reported to be present in the sera of patients with various malignancies, including lung cancer. Using a quantitative immunoassay, we measured p53 protein concentrations in 216 sera from 114 lung cancer p...
Autores principales: | Levesque, M. A., D'Costa, M., Diamandis, E. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074762/ https://www.ncbi.nlm.nih.gov/pubmed/8912541 |
Ejemplares similares
-
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
por: Levesque, M. A., et al.
Publicado: (1995) -
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination
por: Yu, H, et al.
Publicado: (1999) -
p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
por: Schneider, J, et al.
Publicado: (1999) -
S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability
por: Buckley, N E, et al.
Publicado: (2014) -
Prostate-specific antigen in serum of women with breast cancer.
por: Giai, M., et al.
Publicado: (1995)